Molina-León Á, Tudor-Franco C

Language: Spanish
References: 15
Page: 26-32
PDF size: 154.33 Kb.

ABSTRACT

The postsynaptic disorder that represents myasthenia gravis is an autoimmune attack of anti-acetylcholine Ach-receptor antibodies that produces a typical triad: ptosis, diplopia and fatigability, and severely affects the facial and proximal muscles, resulting, among other abnormalities, in weakness of speech, chewing and swallowing, and may even affect the respiratory muscles. We present a case of a 58-year-old male patient, with previous consultations in the emergency department for a month due to severe choking problems, both with solids and liquids. His medical history includes allergy to penicillin, ibuprofen and tramadol, extrinsic bronchial asthma, childhood poliomyelitis and unintervened fracture of the greater trochanter. The patient underwent exhaustive analysis and repetitive distal stimulation and Jitter with proximal axonal microstimulation. The results corroborate the diagnoses used in relation to this muscular etiopathogenesis.

REFERENCES

1. Robertson NP, Deans J, Compston DA. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry. 1998; 65 (4): 492-496.

2. Phillips LH, Torner JC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology. 1996; 47 (5): 1233-1238.

3. Zarranz JJ. Neurología. 5ta ed. Elsevier Castellano; 2013.

4. Caballero Martín MA, Nieto Gómez R, Barcik U. Presentación clínica de miastenia gravis en Atención Primaria: a propósito de un caso. Medifam. 2001; 11 (3).

5. Cabañes L. Evaluación neurofisiológica de las enfermedades de la unión neuromuscular. Servicio de neurofisiología clínica. Congreso. 2015. Universidad de Alcalá.

6. Kouyoumdjian , Stolber 120212 kouyoumdjian , Stolber : Jitter with concentric electrodes .

7. Linstrom JM, Seybold ME, Lennon VD et al. Antibody to acetylcoline receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976; 26 (11): 1054-1059.

8. Schimmbeck PL, Dyrberg T, Drachman DB et al. Molecular mimicry and miasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest. 1989; 84 (4): 1174-1180.

9. Aarli JA. Late-onset myasthenia gravis: a changing scene. Arch Neurol. 1999; 56 (1): 25-27.

10. 10 . Aarli JA, Stefansson K, Marton LS, Wallmann RL. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Inmunol 1990; 82: 284-8.

11. Drachman DB. Miastenia grave. En: Harrison's. Principios de Medicina Interna. 14ª ed. Interamericana Mac Gray-Hill, 1998.

12. Fujita J, Yamadori I, Yamaji Y et al. Myasthenia Gravis associated with small-cell carcinoma of the lung. Chest. 1994; 105 (2): 624-625.

13. Ramos-Yeo YL, Reyes CV. Myasthenic syndrome (Eaton-Lambert syndrome) associated with pulmonary adenocarcinoma. J Surg Oncol. 1987; 34 (4): 239-242.

14. Vega-Garces WJ, Aguilera-Pacheco O, Núñez-Gil M et al. Miastenia gravis en pacientes mayores de 50 años. Rev Neurol. 1999; 28: 948-951.

15. Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty year experience in over 1.200 patients. Mt Sinai J Med 1971; 38: 497-537.